5 Amendments of Eleftherios SYNADINOS related to 2016/2057(INI)
Amendment 6 #
Draft opinion
Recital Α
Recital Α
Α. whereas guaranteeing universal access to medicines presents a myriad of challenges; whereas Article 34 (social security and social assistance) of the Charter of Fundamental Rights of the European Union categorically prohibits exclusion from access to medicines;
Amendment 23 #
Draft opinion
Paragraph 1
Paragraph 1
1. Stresses the importance of observing the principle of subsidiarity, as each Member State must address any shortcomings on the basis of its own particular requirements, strictly adhering to the terms of Article 35 (health care) of the Charter of Fundamental Rights of the EU, regardless of financial indicators;
Amendment 56 #
Draft opinion
Paragraph 4
Paragraph 4
4. Recommends that information sharing and the training of medical professionals be made an immediate priority, particularly regarding the prevention of incurable diseases and cancer;
Amendment 65 #
Draft opinion
Paragraph 5
Paragraph 5
5. Urges that universal access to medicines should not be contingent on price, which should reflect a fair balance between the cost of research, industry growth and the need for sustainable welfare systems, particularly where co- payments for medication are beyond the means of those insured;
Amendment 81 #
Draft opinion
Paragraph 7
Paragraph 7
7. Reiterates that part of the reason why businesses are becoming less competitive and why welfare spending is so high is that EU rules – including rules on drug pricing – are too burdensome, in addition to which, austerity and economic adjustment policies are causing increased unemployment and resulting in welfare cuts.